ORASURE TECHNOLOGIES INC Segments Disclosure
| December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| United States | $ | 36,254 | $ | 40,286 | |||||||
| United Kingdom | 10,061 | 12,849 | |||||||||
| Canada | 4,642 | 5,468 | |||||||||
| Other regions | 364 | 89 | |||||||||
| $ | 51,321 | $ | 58,692 | ||||||||
| For the Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Net revenues | $ | 115,021 | $ | 185,827 | 405,472 | ||||||||||||
Cost of products and services sold (3) | 66,823 | 106,437 | 233,820 | ||||||||||||||
| Gross profit | 48,198 | 79,390 | 171,652 | ||||||||||||||
Research and development (3) | 42,528 | 26,047 | 33,728 | ||||||||||||||
Sales and marketing (3) | 26,117 | 30,986 | 36,319 | ||||||||||||||
General and administrative (3) | 47,677 | 46,215 | 58,191 | ||||||||||||||
| Loss on impairments | — | 4,392 | 10,829 | ||||||||||||||
| Change in the estimated fair value of acquisition-related contingent consideration | 4,570 | — | (99) | ||||||||||||||
| Gain on sale of assets | (725) | — | — | ||||||||||||||
| Operating (loss) income | (71,969) | (28,250) | 32,684 | ||||||||||||||
Other income (expense) (1) | 229 | (380) | 17,836 | ||||||||||||||
| Interest revenue | 8,078 | 11,469 | 5,862 | ||||||||||||||
Other segment items (2) | (924) | 1,160 | (124) | ||||||||||||||
| (Loss) income before income taxes and equity investment | (64,586) | (16,001) | 56,258 | ||||||||||||||
| Income tax expense | 1,801 | 1,799 | 2,603 | ||||||||||||||
| Loss on equity investment | (2,344) | (1,700) | — | ||||||||||||||
| Net (loss) income | $ | (68,731) | $ | (19,500) | $ | 53,655 | |||||||||||
| For the Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Stock-based Compensation | |||||||||||||||||
| Cost of products and services sold | $ | 707 | 734 | 564 | |||||||||||||
| Research and development | 1,046 | 839 | 1,159 | ||||||||||||||
| Sales and marketing | 863 | 1,129 | 1,181 | ||||||||||||||
| General and administrative | 7,531 | 9,218 | 7,826 | ||||||||||||||
| $ | 10,147 | $ | 11,920 | $ | 10,729 | ||||||||||||
| For the Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Depreciation and Amortization | |||||||||||||||||
| Cost of products and services sold | $ | 4,527 | $ | 6,343 | $ | 15,311 | |||||||||||
| Research and development | 2,081 | 1,029 | 1,208 | ||||||||||||||
| Sales and marketing | 80 | 189 | 571 | ||||||||||||||
| General and administrative | 3,504 | 3,311 | 3,846 | ||||||||||||||
| $ | 10,192 | $ | 10,872 | $ | 20,936 | ||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 9, 2026 | Showing above |
| 2024 | Mar 7, 2025 | |
| 2023 | Mar 11, 2024 | |
| 2022 | Mar 3, 2023 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.